This federal contract award, identified as SPE2DB20D2002|SPE2DB25FL01V, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,867.54, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions.
The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of November 12, 2024. It is not designated as a set-aside contract, indicating open competition.
AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/27/25, 11:16 AM